DASI Simulations earns FDA clearance for second AI-powered imaging product; continues to build structural heart platform
DASI Dimensions offers AI-powered, accurate, efficient pre-procedural measurement for heart valve replacement DUBLIN, OH, UNITED STATES, September 10, 2024 /EINPresswire.com/ — DASI Simulations announced today that its second product – DASI Dimensions – has earned FDA clearance. “Our mission –... Read More →
EXCLUSIVE: Bloomlife Secures $12.2M Series A to Advance Remote Maternal Care Platform
Bloomlife, a leader in maternal health technology, has successfully raised $12.2 million in a Series A funding round, marking a significant step forward in its mission to advance maternal healthcare. The funding round was led by Kapor Capital and European... Read More →
Discure Technologies Announces $16 Million in Financing Led by BOLD Capital Partners, Supernova Invest and Sanara Capital
Funds will advance the clinical testing of Discure’s breakthrough device for degenerative disc disease PETACH-TIKVA, Israel, Sept. 10, 2024 /PRNewswire/ — Discure Technologies Ltd., developer of the Discure System, a bioelectronic implantable device for the treatment of degenerative disc disease... Read More →
GenNext and Agilent Unveil Groundbreaking Technology Integration to Accelerate High-Value Decision Making in Biopharmaceutical Research
Half Moon Bay, CA – September 10, 2024 – Today at CASSSS 2024, GenNext Technologies and Agilent announced a pioneering collaboration that promises to transform structural biology research for biopharmaceutical companies. The integration of GenNext’s AutoFox Protein Footprinting System with... Read More →
HEPTA Medical Secures €5.7 Million Series A, Led by BPI France to Advance Minimally Invasive Lung Cancer Treatment
Founded in 2019 by Sofinnova’s medtech acceleration team, MD Start The funds will be used for the 510(k) regulatory approval process for the first version of HEPTA Medical’s microwave ablation platform and to initiate its clinical trials SURESNES, France–(BUSINESS WIRE)–HEPTA... Read More →
Lungpacer Medical Announces PMA Submission for AeroPace® System
AeroPace is a minimally invasive transvenous diaphragm strengthening neurostimulation therapy designed for quicker liberation from mechanical ventilation FOR IMMEDIATE RELEASE Exton, PA – September 4, 2024 – Lungpacer Medical, a neurostimulation company developing interventional therapies to free patients from mechanical... Read More →
EpiCypher Expands Exclusive Licensing Agreement to Advance CUT&Tag Technology
DURHAM, N.C., Sept. 4, 2024 /PRNewswire/ — EpiCypher®, a trailblazer in epigenetic research technologies, is pleased to announce an exclusive licensing agreement with Fred Hutch Cancer Center. This agreement grants EpiCypher access to pivotal intellectual property (IP) related to CUT&Tag... Read More →
Renata Medical Receives FDA Approval for the Minima Growth Stent, First-of-its-Kind Device for Treating Aortic Coarctation and Pulmonary Artery Stenosis
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Renata Medical today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s first-of-its-kind Minima Growth Stent that’s specifically tailored for neonates, infants, and young children, but also designed to be re-expanded over the... Read More →
Vitestro Achieves CE Marking for Autonomous Blood Drawing Device
UTRECHT, Netherlands, Aug. 28, 2024 /PRNewswire/ — Vitestro, a pioneer in the field of medical robotics, is proud to announce that its innovative automated blood drawing device has received CE marking. This marks a significant milestone for the company, acknowledging... Read More →
Two New FDA-Clearances for Sibel Health Enables Compatibility of Advanced Wearable Sensors to 3rd Party Software Solutions
CHICAGO, Aug. 22, 2024 /PRNewswire/ — Sibel Health announces two additional FDA-clearances enabling its advanced wearable sensors to operate with compatible third party software applications. In order to democratize vital signs globally, Sibel Health is committed to enabling widespread access... Read More →